Principles of odor coding in vertebrates and artificial chemosensory systems

I Manzini, D Schild, C Di Natale - Physiological reviews, 2022 - journals.physiology.org
The biological olfactory system is the sensory system responsible for the detection of the
chemical composition of the environment. Several attempts to mimic biological olfactory …

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review

E Khani, S Khiali, S Beheshtirouy… - European journal of …, 2021 - Elsevier
The acute loss of taste and smell following COVID-19 are hallmark symptoms that affect 20–
85% of patients. However, the pathophysiology and potential treatments of COVID-19 smell …

[HTML][HTML] Application of a translational profiling approach for the comparative analysis of CNS cell types

JP Doyle, JD Dougherty, M Heiman, EF Schmidt… - Cell, 2008 - cell.com
Comparative analysis can provide important insights into complex biological systems. As
demonstrated in the accompanying paper, translating ribosome affinity purification (TRAP) …

Adenosine receptor targets for pain

J Sawynok - Neuroscience, 2016 - Elsevier
The main focus for the development of adenosine targets as analgesics to date has been A
1 Rs due to its antinociceptive profile in various preclinical pain models. The usefulness of …

Distribution, biochemistry and function of striatal adenosine A2A receptors

P Svenningsson, C Le Moine, G Fisone… - Progress in …, 1999 - Elsevier
It is well known that the nucleoside adenosine exerts a modulatory influence in the central
nervous system by activating G protein coupled receptors. Adenosine A2A receptors, the …

Adenosine in the spinal cord and periphery: release and regulation of pain

J Sawynok, XJ Liu - Progress in neurobiology, 2003 - Elsevier
In the central nervous system (CNS), adenosine is an important neuromodulator and
regulates neuronal and non-neuronal cellular function (eg microglia) by actions on …

Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology & therapeutics, 2005 - Elsevier
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats: Involvement of adenosine A1 and A2A receptors

RDS Prediger, LC Batista, RN Takahashi - Neurobiology of aging, 2005 - Elsevier
Caffeine, a non-selective adenosine receptor antagonist, has been suggested as a potential
drug to counteract age-related cognitive decline since critical changes in adenosinergic …

Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms

RDS Prediger - Journal of Alzheimer's Disease, 2010 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting
approximately 1% of the population older than 60 years. Classically, PD is considered to be …

[PDF][PDF] Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies

RN Takahashi, FA Pamplona, RD Prediger - Front Biosci, 2008 - academia.edu
Introduction 3. Basic aspects of adenosine as a neuromodulator relevant for cognitive
functions 4. Effects of adenosine receptor antagonists on cognitive deficits in aged rodents …